SPEC Stock Overview
Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
INSPECS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.56 |
| 52 Week High | UK£0.95 |
| 52 Week Low | UK£0.46 |
| Beta | 2.22 |
| 11 Month Change | 3.67% |
| 3 Month Change | 1.80% |
| 1 Year Change | -27.10% |
| 33 Year Change | -85.13% |
| 5 Year Change | n/a |
| Change since IPO | -71.03% |
Recent News & Updates
INSPECS Group plc's (LON:SPEC) Revenues Are Not Doing Enough For Some Investors
Sep 17
Is INSPECS Group (LON:SPEC) A Risky Investment?
Jun 09INSPECS Group plc (LON:SPEC) Surges 27% Yet Its Low P/S Is No Reason For Excitement
May 04Recent updates
INSPECS Group plc's (LON:SPEC) Revenues Are Not Doing Enough For Some Investors
Sep 17Is INSPECS Group (LON:SPEC) A Risky Investment?
Jun 09INSPECS Group plc (LON:SPEC) Surges 27% Yet Its Low P/S Is No Reason For Excitement
May 04INSPECS Group plc's (LON:SPEC) Shares Lagging The Industry But So Is The Business
Jan 18A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
Oct 30A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
May 23Returns On Capital At INSPECS Group (LON:SPEC) Paint A Concerning Picture
Mar 04A Look At The Fair Value Of INSPECS Group plc (LON:SPEC)
Feb 01INSPECS Group (LON:SPEC) Has A Pretty Healthy Balance Sheet
Dec 06INSPECS Group (LON:SPEC) Might Be Having Difficulty Using Its Capital Effectively
Nov 01Estimating The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
Aug 13Is It Time To Consider Buying Inspecs Group plc (LON:SPEC)?
Jun 23Calculating The Fair Value Of Inspecs Group plc (LON:SPEC)
May 10The Inspecs Group (LON:SPEC) Share Price Is Up 92% And Shareholders Are Holding On
Mar 16What Type Of Shareholders Own The Most Number of Inspecs Group plc (LON:SPEC) Shares?
Feb 09A Look At The Fair Value Of Inspecs Group plc (LON:SPEC)
Dec 17Shareholder Returns
| SPEC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -0.9% | 2.7% | 1.6% |
| 1Y | -27.1% | 17.0% | 10.6% |
Return vs Industry: SPEC underperformed the UK Medical Equipment industry which returned 17% over the past year.
Return vs Market: SPEC underperformed the UK Market which returned 10.6% over the past year.
Price Volatility
| SPEC volatility | |
|---|---|
| SPEC Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: SPEC has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: SPEC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 1,673 | Richard Peck | www.inspecs.com |
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. The company offers its products under the JOSEPH, CAT, Viktor & Rolf, Hype, Henri Lloyd, Barbour, Liberty, O’Neill, Lyle & Scott, SUPERDRY, RADLEY LONDON, Temperly London, TED BAKER LONDON, MINI, L.A.M.B., Barbour International, Marc O’Polo, TALBOT RUNHOF Eyewear, BUFFALO David Bitton, Free Country, BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY’S eyewear, JOS ESCHENBACH, and TITANFLEX brands through optical and retail outlets. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.
INSPECS Group plc Fundamentals Summary
| SPEC fundamental statistics | |
|---|---|
| Market cap | UK£57.44m |
| Earnings (TTM) | -UK£4.11m |
| Revenue (TTM) | UK£195.14m |
0.3x
P/S Ratio-14.0x
P/E RatioIs SPEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SPEC income statement (TTM) | |
|---|---|
| Revenue | UK£195.14m |
| Cost of Revenue | UK£94.73m |
| Gross Profit | UK£100.41m |
| Other Expenses | UK£104.52m |
| Earnings | -UK£4.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 51.46% |
| Net Profit Margin | -2.10% |
| Debt/Equity Ratio | 43.6% |
How did SPEC perform over the long term?
See historical performance and comparison